Former presidential candidates Sens. Elizabeth Warren and Bernie Sanders slammed the Trump administration Thursday for giving Gilead Sciences a “windfall” deal to secure most of the pharmaceutical company’s supply of its coronavirus-fighting drug remdesivir with the United States.
In a new letter addressed to U.S. Health and Human Services Secretary Alex Azar that was obtained by CNBC, Warren, Sanders and other lawmakers said the deal will give Gilead up to $500 million in revenue borne almost entirely by American taxpayers, “in whole or in part” through higher insurance premiums.
…
Read the full article on the CNBC website here.